Trials / Completed
CompletedNCT00803335
The Effects of Local Vaginal Estrogen in Postmenopausal Women With Pelvic Organ Prolapse
The Effects of Local Vaginal Estrogen in Postmenopausal Women With Pelvic Organ Prolapse: A Randomized Control Trial
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 54 (actual)
- Sponsor
- TriHealth Inc. · Academic / Other
- Sex
- Female
- Age
- 45 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to find out how long it takes the vagina to respond to hormonal vaginal cream in women with pelvic organ prolapse (bulge in the vagina). It also will address the appropriate amount to use prior to vaginal repair of pelvic organ prolapse.
Detailed description
Subjective and objective vaginal health symptoms, validated pelvic floor questionnaires, cytology and histology will be analyzed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vaginal conjugated estrogen cream 0.5gm | Women in this arm will apply 0.5gm vaginal estrogen cream nightly until surgery. |
| DRUG | Vaginal conjugated estrogen cream 1.0gm | Women in this arm will apply 1.0gm vaginal estrogen cream nightly until surgery. |
Timeline
- Start date
- 2008-12-01
- Primary completion
- 2011-05-01
- Completion
- 2011-05-01
- First posted
- 2008-12-05
- Last updated
- 2015-05-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00803335. Inclusion in this directory is not an endorsement.